134 related articles for article (PubMed ID: 17875718)
1. Identification and characterization of genetic variation in the folylpolyglutamate synthase gene.
Leil TA; Endo C; Adjei AA; Dy GK; Salavaggione OE; Reid JR; Ames MM; Adjei AA
Cancer Res; 2007 Sep; 67(18):8772-82. PubMed ID: 17875718
[TBL] [Abstract][Full Text] [Related]
2. Enzyme inhibition, polyglutamation, and the effect of LY231514 (MTA) on purine biosynthesis.
Mendelsohn LG; Shih C; Chen VJ; Habeck LL; Gates SB; Shackelford KA
Semin Oncol; 1999 Apr; 26(2 Suppl 6):42-7. PubMed ID: 10598554
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
Zhao R; Babani S; Gao F; Liu L; Goldman ID
Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
[TBL] [Abstract][Full Text] [Related]
4. Folylpoly-gamma-glutamate synthetase: generation of isozymes and the role in one carbon metabolism and antifolate cytotoxicity.
Qi H; Atkinson I; Xiao S; Choi YJ; Tobimatsu T; Shane B
Adv Enzyme Regul; 1999; 39():263-73. PubMed ID: 10470377
[TBL] [Abstract][Full Text] [Related]
5. Folylpolyglutamate synthetase expression in antifolate-sensitive and -resistant human cell lines.
McGuire JJ; Russell CA
Oncol Res; 1998; 10(4):193-200. PubMed ID: 9778690
[TBL] [Abstract][Full Text] [Related]
6. DL-beta,beta-difluoroglutamic acid mediates position-dependent enhancement or termination of pteroylpoly(gamma-glutamate) synthesis catalyzed by folylpolyglutamate synthetase.
McGuire JJ; Hart BP; Haile WH; Rhee MS; Galivan J; Coward JK
Arch Biochem Biophys; 1995 Aug; 321(2):319-28. PubMed ID: 7646057
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of the reduced folate carrier and folypolyglutamate synthetase is the basis for acquired resistance to the pemetrexed antifolate (LY231514) in an L1210 murine leukemia cell line.
Wang Y; Zhao R; Goldman ID
Biochem Pharmacol; 2003 Apr; 65(7):1163-70. PubMed ID: 12663051
[TBL] [Abstract][Full Text] [Related]
8. Differing specificities for 4-aminofolate analogues of folylpolyglutamyl synthetase from tumors and proliferative intestinal epithelium of the mouse with significance for selective antitumor action.
Rumberger BG; Barrueco JR; Sirotnak FM
Cancer Res; 1990 Aug; 50(15):4639-43. PubMed ID: 2369741
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of folylpolyglutamate synthetase gene expression in tumor tissues by the polymerase chain reaction: marked variation of expression among leukemia patients.
Lenz HJ; Danenberg K; Schnieders B; Goeker E; Peters GJ; Garrow T; Shane B; Bertino JR; Danenberg PV
Oncol Res; 1994; 6(7):329-35. PubMed ID: 7865908
[TBL] [Abstract][Full Text] [Related]
10. Human aromatase: gene resequencing and functional genomics.
Ma CX; Adjei AA; Salavaggione OE; Coronel J; Pelleymounter L; Wang L; Eckloff BW; Schaid D; Wieben ED; Adjei AA; Weinshilboum RM
Cancer Res; 2005 Dec; 65(23):11071-82. PubMed ID: 16322257
[TBL] [Abstract][Full Text] [Related]
11. Purification and properties of human cytosolic folylpoly-gamma-glutamate synthetase and organization, localization, and differential splicing of its gene.
Chen L; Qi H; Korenberg J; Garrow TA; Choi YJ; Shane B
J Biol Chem; 1996 May; 271(22):13077-87. PubMed ID: 8662720
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier.
Wang Y; Zhao R; Goldman ID
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6256-64. PubMed ID: 15448015
[TBL] [Abstract][Full Text] [Related]
13. Mammalian mitochondrial and cytosolic folylpolyglutamate synthetase maintain the subcellular compartmentalization of folates.
Lawrence SA; Titus SA; Ferguson J; Heineman AL; Taylor SM; Moran RG
J Biol Chem; 2014 Oct; 289(42):29386-96. PubMed ID: 25164808
[TBL] [Abstract][Full Text] [Related]
14. [Pemetrexed: from preclinic to clinic].
Lansiaux A; Lokiec F
Bull Cancer; 2007; 94 Spec No Actualites():S134-8. PubMed ID: 17845983
[TBL] [Abstract][Full Text] [Related]
15. Different antifolate-resistant L1210 cell variants with either increased or decreased folylpolyglutamate synthetase gene expression at the level of mRNA transcription.
Roy K; Mitsugi K; Sirlin S; Shane B; Sirotnak FM
J Biol Chem; 1995 Nov; 270(45):26918-22. PubMed ID: 7592937
[TBL] [Abstract][Full Text] [Related]
16. Genetic diversity and function in the human cytosolic sulfotransferases.
Hildebrandt MA; Carrington DP; Thomae BA; Eckloff BW; Schaid DJ; Yee VC; Weinshilboum RM; Wieben ED
Pharmacogenomics J; 2007 Apr; 7(2):133-43. PubMed ID: 16801938
[TBL] [Abstract][Full Text] [Related]
17. Folate analogues as substrates of mammalian folylpolyglutamate synthetase.
Schoo MM; Pristupa ZB; Vickers PJ; Scrimgeour KG
Cancer Res; 1985 Jul; 45(7):3034-41. PubMed ID: 3873989
[TBL] [Abstract][Full Text] [Related]
18. A novel folate transport activity in human mesothelioma cell lines with high affinity and specificity for the new-generation antifolate, pemetrexed.
Wang Y; Zhao R; Chattopadhyay S; Goldman ID
Cancer Res; 2002 Nov; 62(22):6434-7. PubMed ID: 12438230
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human liver folylpolyglutamate synthetase by non-gamma-glutamylatable antifolate analogs.
Clarke L; Rosowsky A; Waxman DJ
Mol Pharmacol; 1987 Jan; 31(1):122-7. PubMed ID: 3807889
[TBL] [Abstract][Full Text] [Related]
20. Effects of folate and folylpolyglutamyl synthase modulation on chemosensitivity of breast cancer cells.
Cho RC; Cole PD; Sohn KJ; Gaisano G; Croxford R; Kamen BA; Kim YI
Mol Cancer Ther; 2007 Nov; 6(11):2909-20. PubMed ID: 18025275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
